The burgeoning cannabis industry attracted many investors ever since cannabis changed its status from being a criminalized drug to a multi-billion dollar business. Companies like ADREXPharma and World High Life PLC (NEX: LIFE) are serious competitors in this rapidly growing sector.
After one year of intensive development work, ADREXpharma has developed a medical skincare product which, for the first time, combines the latest findings from current hemp care research: ADREXOLIN. It is a body and face lotion with cannabidiol (CBD) for a basic daily care of dry, irritated, scaly or itchy skin.
ADREXOLIN – Natural cosmetics with deep care
The aim of the holistic development work was to use only purely natural ingredients from the field of natural cosmetics. Therefore, ADREXOLIN is free of parabens, paraffin, silicone and mineral oils and does not contain any synthetic fragrances or preservatives. The innovative formula with 100% natural, vegetable active ingredients such as tea tree oil, lavender, rosemary oil, and hemp seed oil is antibacterial and anti-inflammatory. The anti-inflammatory and antibacterial properties of cannabidiol support the regeneration of the skin. ADREXOLIN can sustainably improve the skin condition and immediately alleviate irritations of the skin.
ADREXpharma – Driving Innovation in the European Cannabis Industry
ADREXpharma is a medium-sized, independent pharmaceutical company that specializes in the development, manufacture, and marketing of various dosage forms for medical cannabis.
The company based in Koblenz was founded in the spring of 2018, by Mario Eimuth and two partners from the pharmaceutical industry The current product portfolio consists of ingredients for prescription drugs such as cannabidiol and dronabinol, cannabis flowers, THC extracts, and optional products. Only pharmacies and wholesalers are supplied nationwide.
World High Life plans to dominate the new European frontier market
The regulatory frameworks are rapidly changing in Europe and countries are starting to adopt more cannabis-friendly laws. As such, the number of investors and companies interested in taking advantage of the new frontier market is increasing.
World High Life PLC (NEX: LIFE) is a UK-based cannabis investment company that plans to create a portfolio of the most promising cannabis and CBD companies in Europe. In this regard, WHL has just acquired Britain’s top hemp producer, Love Hemp, in a transaction valued at 9 million GBP. Love Hemp produces a variety of CBD products such as sprays, vapes, oils, edibles, CBD-infused beverages, and cosmetics and sells its products in 1,200 UK high street stores. Additionally, they have agreements with big networks such as Boots, Tesco, Superdrug and Sainsbury’s. With Love Hemp, WHL plans to expand into other European markets, starting with Germany in 2020.
World High Life’s management team has decades of experience in the North-American cannabis market and plans to transfer their know-how to the fast-growing European cannabis sector. By purchasing a single stock, investors will be able to access a portfolio of top companies. WHL’s experts will assure you won’t miss out on the new opportunities that will continue to occur in the European cannabis market.
More European countries started to move out the limbo when it comes to legal cannabis. As a result, companies and investors have the opportunity of making profits in the new European frontier market that is expected to overtake the North-American cannabis market.